Olympus today announced a new strategy that aims to increase cost savings but includes a workforce reduction of thousands.
Olympus will now look to shake off the controversies its endoscopy business has faced in the last couple of years.
The company is moving to a leaner, divisional model, with a planned target of 3% annual sales growth by fiscal 2027.
Olympus Corporation (Olympus), a global MedTech leader dedicated to making people’s lives healthier, safer, and more ...
An announcement from Olympus ( ($JP:7733) ) is now available. Olympus Corporation has completed a share repurchase program and announced the ...